Opinion/decision on a Paediatric investigation plan (PIP): Sarclisa,Isatuximab, decision type: , therapeutic area: , PIP number: P/0494/2022
Opinion/decision on a Paediatric investigation plan (PIP): Sarclisa,Isatuximab, decision type: , therapeutic area: , PIP number: P/0494/2022
